Alsatinib 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Alsatinib 50 mg Tablet

Alsatinib 50 mg Tablet

Alsatinib 50 mg Tablet contains dasatinib, a targeted anticancer medicine used to treat certain blood cancers. Each tablet contains 50 mg of dasatinib and is taken orally as prescribed by a healthcare professional. It is used for conditions including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that blocks abnormal proteins involved in the growth and survival of leukemia cells. By targeting these signaling pathways, it helps slow the multiplication of abnormal blood cells. Alsatinib may be prescribed according to the patient’s diagnosis, disease status, and response to treatment. Regular blood tests and medical monitoring are important during therapy to assess treatment response and manage possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size Bottle of 60 Tablets
Manufacturer Alkem Laboratories Ltd

Product Also Known As

Alsatinib 50 mg Tablet, Dasatinib 50 mg Tablet, Alsatinib Dasatinib Tablet, Dasatinib Anticancer Tablet, Alsatinib Leukemia Treatment Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet